Article
Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets.
Head & neck - 1 Jul 2017
Ashford Bruce G, Clark Jonathan, Gupta Ruta, Iyer N Gopalakrishna, Yu Bing, Ranson Marie
Abstract excerpt
Cutaneous squamous cell carcinoma (SCC) is second only in incidence to basal cell carcinoma (BCC), effecting up to 500 000 people in the United States annually. Metastasis to regional lymph nodes occurs in approximately 5% of cases and imparts significant morbidity. Standard treatment in this group involves a combination of surgery and adjuvant radiation. Currently, there are no clinically useful biomarkers of...
Read the complete abstract on PubMedTopics
- Biomarkers, Tumor
- Carcinoma, Squamous Cell
- Female
- Genetic Predisposition to Disease
- Genetic Variation
- Humans
